10 articles
A study shows LLM chatbots give unreliable medical advice. In tests, people using AI were less likely to correctly diagnose conditions than those not using AI. Issues include users omitting key details and chatbots giving inconsistent or incorrect information.
GLP-1 drugs quickly transformed weight management, creating shortages and ethical dilemmas over prescribing them for weight loss versus diabetes.
Hims & Hers buys Australia's Eucalyptus for $240M, aiming to expand telehealth services into the UK, Germany, Canada, Australia, and Japan.
STAT's D.C. Diagnosis newsletter covers health policy. Dr. Oz made a crude poop analogy, and the White House aims to codify Trump-era drug pricing deals.
A national directory of doctors with current info is months away, aiming to fix long-standing errors in insurance provider lists.
Grail's cancer blood test failed its main goal in a large NHS study, causing its stock to drop 47%.
Texas AG Paxton sues Sanofi, alleging it gave doctors free nursing and insurance support as kickbacks to boost prescriptions of its drugs for chronic illnesses.
DeepRare is an AI system using large language models to diagnose rare diseases. It analyzes patient data to suggest ranked diagnoses with evidence, outperforming existing methods and showing high accuracy in global tests.
HBO's medical drama "The Pitt" explores the pros and cons of generative AI in hospitals, showing it can create efficiency but also errors and extra work, while highlighting deeper issues like understaffing that tech can't solve.
A UK medical center displayed system usernames and passwords on a public whiteboard, highlighting a major security flaw despite guidelines. This underscores human error as a key vulnerability, with passkeys suggested as a more secure future alternative.